News

Blog

Lessons of NET Cancer

PRRT Patients Tell Their Stories Following the early 2018 FDA approval of the first Peptide Receptor Radionuclide Therapy (PRRT) using lutetium Lu-177 dotatate, many people are

Read More »
Blog

Exercise and Cancer

[breakout] Talk to your doctor before changing your activity level. You may need to make important modifications based on medication you are taking, surgery you

Read More »